SAB Biotherapeutics, Inc. (SABS) Presents at FOCIS 2026 Annual Meeting - Slideshow (NASDAQ:SABS) 2026-06-10
SAB Biotherapeutics stock maintains Buy rating at H.C. Wainwright on positive diabetes treatment data
SAB Biotherapeutics, Inc. (SABS) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release